Today: 10 April 2026
German stock market today: DAX clings to record highs as German inflation test nears
6 January 2026
2 mins read

German stock market today: DAX clings to record highs as German inflation test nears

Frankfurt, Jan 6, 2026, 10:52 CET — Regular session

  • Germany’s DAX was up about 0.1% near record highs in morning trade.
  • A services survey still points to expansion, but cost pressures remain elevated.
  • Traders are watching German December inflation and a run of factory surveys for rate clues.

Germany’s blue-chip DAX index was up about 0.1% at 24,887 points on Tuesday, holding close to record territory as European stocks steadied after a strong start to the year. German 10-year borrowing costs eased and gold edged higher, a backdrop that has helped keep risk appetite firm. Reuters

The small gain followed a surge that pushed benchmarks deeper into uncharted territory, with investors leaning on a growth narrative for 2026 and hoping Germany’s fiscal stance will add support. Strategists at Goldman Sachs have flagged German fiscal stimulus as a key prop for euro zone growth, while traders braced for German inflation figures and a fresh batch of manufacturing readings later in the day. Reuters

Economic data early on Tuesday showed Germany’s service sector remained in expansion mode at the end of 2025, even as momentum cooled. “The moderate growth in new business suggests that the start to the new year could be satisfactory,” said Cyrus de la Rubia, chief economist at Hamburg Commercial Bank, after the final HCOB services PMI printed at 52.7 in December — above the 50 level that separates growth from contraction. Reuters

Across the currency bloc, euro zone activity also stayed in growth territory, with the final composite PMI easing to 51.5 in December. “GDP growth is likely to have accelerated,” de la Rubia said, while warning that sticky service-sector price pressures are a key factor for an ECB that has been cautious on further rate cuts. Reuters

Defence remained a key pillar of the rally after geopolitical tensions flared at the weekend, lifting the sector across Europe and helping propel Germany’s benchmark to records on Monday. “It demonstrates that, despite the geopolitical instability around the globe, investors feel confident in the way markets are progressing,” said Danni Hewson, head of financial analysis at AJ Bell, as Rheinmetall led DAX gainers with a roughly 9% jump. Reuters

Strategists have also been leaning more constructive on European equities as the rally broadens. Goldman Sachs on Tuesday raised its 12-month STOXX 600 target to 625, saying, “Valuation is supported by strong global growth and falling interest rates in the U.S.” The bank noted the index’s 12-month forward price-to-earnings ratio — a valuation measure that compares share prices with expected earnings — is around 18, versus about 28 for the S&P 500. Reuters

But record levels can cut both ways. A firmer-than-expected German inflation print could reset rate expectations and squeeze the most rate-sensitive stocks, while any renewed energy shock tied to Venezuela would test the market’s calm.

Next up is a heavy data docket, with Germany and France due to publish December CPI figures and multiple December PMI readings across Europe and the United States. For Frankfurt traders, the immediate catalyst is Germany’s December inflation data due later on Tuesday. Reuters

Stock Market Today

  • Oricell Therapeutics Raises $110 Million Pre-IPO to Boost CAR-T Cancer Therapies
    April 9, 2026, 8:35 PM EDT. Oricell Therapeutics secured over $110 million in a pre-IPO funding round, led by Vivo Capital and other global investors, to advance its innovative CAR-T therapies targeting solid tumors. The biotech company is focusing on its lead asset, Ori-C101, a CAR-T therapy for advanced liver cancer that has shown promising clinical trial results and is preparing for pivotal trials. Oricell's proprietary technology platforms aim to strengthen its position in the competitive CAR-T therapy landscape. Chairman Huanfeng Yang emphasized the company's commitment to accelerating global development and pioneering next-generation cancer immunotherapies, including in vivo CAR-T programs, aiming to transform treatment for solid tumors, traditionally a challenging area in oncology.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
China Stock Market Today: Shanghai, CSI 300 close at decade highs on metals surge — CPI in focus
Previous Story

China Stock Market Today: Shanghai, CSI 300 close at decade highs on metals surge — CPI in focus

Singapore Stock Market Today: STI Ends at Fresh Record Close as DBS, OCBC Lead Rally
Next Story

Singapore Stock Market Today: STI Ends at Fresh Record Close as DBS, OCBC Lead Rally

Go toTop